L-type calcium channel blocker attenuates doxorubicine-induced cardiomyopathy by inhibiting CaMKII-NF-kB axis

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Ion channels - Related pathologies Cardiomyopathies ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by